Efficacy and safety of robotic assisted thoracoscopic esophagectomy and mediastinal lymphadenectomy using the da Vinci surgical system for thoracic esophageal cancer

Efficacy and safety of robotic assisted thoracoscopic esophagectomy and mediastinal lymphadenectomy using the da Vinci surgical system for thoracic esophageal cancer - Robotic assisted thoracoscopic esophagectomy and mediastinal lymphadenectomy

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009727

Enrollment

Registered

2013-01-10

Start date

2013-01-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic esophageal cancer

Interventions

Introduce a robotic assisted thoracoscopic esophagectomy and mediastinal lymphadenectomy for resectable thoracic esophageal cancer patients.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: resectable thoracic esophageal cancer

Exclusion criteria

Exclusion criteria: patient with a history of an intrathoracic surgery patient with an esophago-bronchial fistulae in case of an emergency operation

Design outcomes

Primary

Measure	Time frame
completion rate of the robotic assisted surgery total adverse event rate	—

Secondary

Measure	Time frame
duration of operation intraoperative blood loss incidence of a recurrent nerve palsy length of postoperative hospital stay	—

Countries

Japan

Contacts

Public ContactTakashi Kamei

Tohoku University Hospital Division of transplantation, reconstruction and endoscopic surgery

tkamei@med.tohoku.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026